Probi and Clasado Biosciences announced it will launch new scientifically proven synbiotic formulations. There is a rising interest and awareness in health and nutrition, where consumers seek ways to improve digestive, immune, and overall health. High consumer awareness together with prevalent marketing are the major factors driving the demand for synbiotic products, as the growing health consciousness among consumers is expected to drive market growth in synbiotic, with a projected annual growth rate of 8.3% from 2020 to 2027 globally.

At this year's Supply Side West, in Las Vegas, Probi and Clasado will launch two new synbiotic solutions: Bimuno GOS and Probi Defendum which demonstrate a clear synergistic synbiotic combination as the probiotic strains in Probi Defendum selectively utilize the prebiotic GOS to enhance the production of short chain fatty acids. Bimuno G OS and Probi Digestis that showcases complementary mechanisms of action and enter the market as the most researched synbiotic ingredient pairing, with extensive studies behind both ingredients covering almost 340 publications between them.